SMAD3 and Wilson disease: In conclusion, this work indicates that disruption of the SMAD3 adaptor, βII-spectrin/TGF-β signaling pathway, exacerbated by a HFD or WD, significantly alters the gut microbiome, driving inflammation, and promoting oncogenesis.